Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Current Assets (2016 - 2025)

Historic Current Assets for Iradimed (IRMD) over the last 13 years, with Q3 2025 value amounting to $84.9 million.

  • Iradimed's Current Assets rose 1431.33% to $84.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $84.9 million, marking a year-over-year increase of 1431.33%. This contributed to the annual value of $75.2 million for FY2024, which is 99.85% down from last year.
  • Latest data reveals that Iradimed reported Current Assets of $84.9 million as of Q3 2025, which was up 1431.33% from $77.4 million recorded in Q2 2025.
  • Over the past 5 years, Iradimed's Current Assets peaked at $84.9 million during Q3 2025, and registered a low of $61.3 million during Q1 2023.
  • Its 5-year average for Current Assets is $72.3 million, with a median of $71.9 million in 2023.
  • Per our database at Business Quant, Iradimed's Current Assets soared by 1962.64% in 2021 and then plummeted by 643.51% in 2023.
  • Over the past 5 years, Iradimed's Current Assets (Quarter) stood at $76.2 million in 2021, then grew by 1.63% to $77.5 million in 2022, then dropped by 1.92% to $76.0 million in 2023, then dropped by 1.0% to $75.2 million in 2024, then grew by 12.86% to $84.9 million in 2025.
  • Its last three reported values are $84.9 million in Q3 2025, $77.4 million for Q2 2025, and $75.1 million during Q1 2025.